Obesity Drug Boom, Split Make This Stock a Heavy Bargain

unlock icon  Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Upgrade Now See Benefits

or

Already have an account? Log in here.

Should You Invest $1,000 in Novo Nordisk A/S Right Now?

Before you consider Novo Nordisk A/S, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novo Nordisk A/S wasn't on the list.

While Novo Nordisk A/S currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report
Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Novo Nordisk A/S (NVO)
3.9326 of 5 stars
$39.53-2.9%2.07%9.97Hold$59.44
Eli Lilly and Company (LLY)
3.7976 of 5 stars
$1,389.47-1.8%0.50%45.18Moderate Buy$1,422.00
Mondelez International (MDLZ)
4.3355 of 5 stars
$66.58-0.3%3.12%21.03Moderate Buy$69.30
Nestle (NSRGY)
0.9678 of 5 stars
$101.95-1.0%2.46%N/AHoldN/A

Featured Articles and Offers

Related Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines